We are live on ! Find out more
BSX icon

Boston Scientific

1,404 hedge funds and large institutions have $111B invested in Boston Scientific in 2024 Q3 according to their latest regulatory filings, with 166 funds opening new positions, 567 increasing their positions, 479 reducing their positions, and 76 closing their positions.

New
Increased
Maintained
Reduced
Closed

118% more first-time investments, than exits

New positions opened: 166 | Existing positions closed: 76

18% more repeat investments, than reductions

Existing positions increased: 567 | Existing positions reduced: 479

6% more funds holding

Funds holding: 1,324 → 1,404 (+80)

0% more funds holding in top 10

Funds holding in top 10: 36 → 36 (0)

0.41% less ownership

Funds ownership: 90.33% → 89.93% (-0.41%)

6% less capital inflows, than outflows

Capital inflows: $4.11B | Capital outflows: $4.38B

30% less call options, than puts

Call options by funds: $661M | Put options by funds: $944M

Holders
1,404
Holders Change
+80
Holders Change %
+6.04%
% of All Funds
20.08%
Holding in Top 10
36
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.51%
New
166
Increased
567
Reduced
479
Closed
76
Calls
$661​M
Puts
$944​M
Net Calls
-⁠$283​M
Net Calls Change
-⁠$257​M

BSX Hedge Fund Activity: Q3 2024 in Review

1,404 of the 6,991 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q3 2024, worth a combined $111B — up 8.7% from $102B a quarter earlier.

Buyers outnumbered sellers: 166 funds opened new BSX positions and 76 closed out — a net gain of 90 holders — while 567 added to existing stakes and 479 trimmed.

The largest buyer was AustralianSuper, adding an estimated $206M. The largest seller was Fidelity Investments, cutting an estimated $494M.

  • 1,404 institutional investors held Boston Scientific (BSX) as of Q3 2024, up from 1,324 in Q2 2024.
  • Funds reported $111B of Boston Scientific stock for Q3 2024, up 8.7% quarter-over-quarter.
  • 166 funds opened new Boston Scientific positions in Q3 2024 and 76 closed out, a net change of +90 holders.
  • The largest Boston Scientific buyer in Q3 2024 was AustralianSuper, an estimated $206M added.
  • The largest Boston Scientific seller in Q3 2024 was Fidelity Investments, an estimated $494M sold.

Based on aggregated 13F filings for Q3 2024.